Sung Bin Lee
Gibson Dunn & Crutcher LLPGeneral
Experience5 yrs
Elite Ratings
--
Practice Areas
Biotech (10 cases)
Comp. Arch. and Software (1 case)
Software, Security (1 case)
Communications (1 case)
Ratings
Experience
Grade
Trend
DCT
L1
C
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 2:25-CV-00533 | Yillio Inc v. Uber Tech Inc | 05/16/25 | Challenger | |
| 1:23-CV-00026 | Novartis Pharma Corp v. HEC Pharm Co Ltd | 01/11/23 | Patent Owner | |
| 2:22-CV-00394 | General Access Solutions Ltd v. Cellco Partnership | 10/10/22 | Challenger | |
| 1:22-CV-00431 | Dana Farber Cancer Institute Inc v. Intas Biopharmaceuticals | 06/07/22 | ||
| 1:22-CV-00744 | Novartis Pharma Corp v. Accord Healthcare Inc | 06/06/22 | ||
| 1:22-CV-00352 | Novartis v. Handa Neuroscience LLC | 03/21/22 | ||
| 1:21-CV-01107 | Novartis Pharma Corp v. Lotus Pharmaceutical Co Ltd | 07/30/21 | ||
| 3:21-CV-14428 | Dana Farber Cancer Institute Inc v. DR Reddys Laboratories | 07/30/21 | ||
| 1:21-CV-01105 | Novartis Pharma Corp v. Lupin Inc | 07/29/21 | Patent Owner | |
| 1:21-CV-01106 | Novartis Pharma Corp v. DR Reddys Laboratories Inc | 07/29/21 |